GlassScriptPhysician profile
Vijay M Patel
NPI 1336123439
$25,757.17
in general payments reported to CMS, 2019-2025
55 companies · $5,146 in 2025
The $5,146 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,851 · 2020: $2,924 · 2021: $2,740 · 2022: $3,041 · 2023: $5,031 · 2024: $4,024 · 2025: $5,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,231 · Education: $332 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,488.14 |
| Travel and Lodging | $1,230.58 |
| Education | $331.99 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,307.60 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $2,790.90 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Harmony Biosciences LLC | $1,728.26 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $1,660.51 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Genzyme Corporation | $1,649.34 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $1,555.65 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,161.42 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Sunovion Pharmaceuticals INC. | $903.34 | 2019-2021 | |
| Abbott Laboratories | $773.66 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Epic |
| Medtronic, INC. | $698.28 | 2023 | Corevalve Evolut R |
| Insmed, INC. | $646.84 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $616.58 | 2019-2024 | Yupelri |
| Electromed, INC. | $610.29 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $549.82 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $528.34 | 2019-2024 | Tyvaso |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $512.51 | 2021-2025 | Xembify, Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $425.37 | 2019-2025 | Inspire |
| Verona Pharma, INC. | $371.17 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $354.55 | 2023-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $327.78 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| Takeda Pharmaceuticals U.S.A., INC. | $321.42 | 2020-2025 | Cuvitru |
| Pfizer INC. | $290.00 | 2019-2025 | |
| Eisai INC. | $279.01 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $262.40 | 2020-2025 | |
| Amgen INC. | $179.85 | 2022-2025 | Tezspire |
| Baxter Healthcare | $177.65 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Zoll Respicardia, INC. | $176.93 | 2019 | |
| Ani Pharmaceuticals, INC. | $162.50 | 2023-2025 | Purified Cortrophin Gel |
| Edwards Lifesciences Corporation | $159.18 | 2022 | |
| Cvrx, INC. | $154.49 | 2023 | Barostim Neo System |
| Pulmonx Corporation | $149.30 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Mallinckrodt Enterprises LLC | $145.08 | 2019 | |
| Shire North American Group INC | $141.14 | 2019 | |
| Mallinckrodt Hospital Products INC. | $118.40 | 2021-2025 | Acthar |
| Csl Behring | $103.32 | 2023-2025 | Hizentra |
| Sanofi-Aventis U.S. LLC | $98.61 | 2021-2023 | |
| Inogen, INC. | $92.20 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $64.69 | 2020-2021 | |
| Lilly USA, LLC | $63.58 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $51.56 | 2020-2022 | |
| Medtronic USA, INC. | $44.82 | 2019 | |
| Genentech USA, INC. | $44.62 | 2019-2020 | |
| Stryker Corporation | $40.43 | 2022 | |
| Tactile Systems Technology INC | $36.10 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| 3b Medical, INC. | $34.28 | 2024 | Luna |
| Novartis Pharmaceuticals Corporation | $29.14 | 2019-2020 | |
| Novo Nordisk INC | $25.92 | 2019 | |
| Circassia INC. | $24.46 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $21.62 | 2025 | Lumryz |
| Optinose US, INC. | $21.58 | 2021 | |
| Philips North America LLC | $20.03 | 2025 | Vest Therapy Und |
| Vifor Pharma, INC. | $17.76 | 2024 | Zemaira |
| Allergan, INC. | $13.97 | 2020 | |
| Veran Medical Technologies, INC. | $12.92 | 2021 | |
| Janssen Pharmaceuticals, INC | $6.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.